Long-term, heavy ketamine use is associated with memory problems, depression and anxiety. The drug may also cause ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

The FDA has published its long-awaited update to guidance to make sure clinical trials more closely reflect the range of patients that might be treated with a new therapy in the real world.

They’re mainly used to reduce the appearance of wrinkles. Daxxify is newer than Botox, with the FDA approving it in 2022. Botox has been approved since 2002. Daxxify and Botox both contain the ...